Sirtex touts 1st administration of yttrium-90 microspheres in China

By staff writers

October 11, 2021 -- Radiation oncology firm Sirtex Medical is highlighting the successful first administration of its SIR-Spheres yttrium-90 resin microspheres in China.

The first selective internal radiation therapy (SIRT) procedure using the microspheres was successfully performed for a patient with hepatocellular carcinoma on September 28 at Boao Super Hospital in the Hainan Province. The company hit this milestone with support from partners China Grand Pharmaceutical and Healthcare Holdings, it said.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking